HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study

被引：0
|
作者：
Marianne Harris
Bruce Ganase
Birgit Watson
P. Richard Harrigan
Julio S. G. Montaner
Mark W. Hull
机构：
[1] British Columbia Centre for Excellence in HIV/AIDS,AIDS Research Program
[2] St. Paul’s Hospital,Department of Family Practice, Faculty of Medicine
[3] University of British Columbia,Division of AIDS, Faculty of Medicine
[4] University of British Columbia,undefined
来源：
AIDS Research and Therapy | / 14卷
关键词：
HIV; Antiretrovirals; Elvitegravir; Cobicistat; Darunavir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study
    Harris, Marianne
    Ganase, Bruce
    Watson, Birgit
    Harrigan, P. Richard
    Montaner, Julio S. G.
    Hull, Mark W.
    [J]. AIDS RESEARCH AND THERAPY, 2017, 14 : 1 - 9
  • [2] Darunavir/elvitegravir/emtricitabine/tenofovir-disoproxil-fumarate/cobicistat/voriconazoleDecrease in AUC for darunavir and voriconazole: case report
    [J]. Reactions Weekly, 2017, 1659 (1) : 94 - 94
  • [3] Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection
    Nozza, Silvia
    Poli, Andrea
    Ripa, Marco
    Galli, Laura
    Chiappetta, Stefania
    Spagnuolo, Vincenzo
    Rovelli, Cristina
    Lazzarin, Adriano
    Castagna, Antonella
    Tambussi, Giuseppe
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (02) : 632 - 633
  • [4] Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adults
    Bonora, Stefano
    Calcagno, Andrea
    Trentalange, Alice
    Di Perri, Giovanni
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (03) : 409 - 419
  • [5] Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet for HIV-1 Infection Treatment
    Olin, Jacqueline L.
    Spooner, Linda M.
    Klibanov, Olga M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (12) : 1671 - 1677
  • [6] Comment on: Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection
    Ambrosioni, Juan
    Mosquera, Maria M.
    Miro, Jose M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (05) : 1548 - 1549
  • [7] Strategic simplification: the efficacy and safety of switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) plus darunavir (DRV) in treatment-experienced HIV-1 infected adults (NCT01968551)
    Huhn, G.
    Gallant, J.
    Wilkin, T.
    Callebaut, C.
    Fordyce, M.
    Das, M.
    Mccallister, S.
    Yau, S.
    [J]. HIV MEDICINE, 2016, 17 : 15 - 15
  • [8] Stribild® (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate): A New Paradigm for HIV-1 Treatment
    Manzardo, Christian
    Gatell, Jose M.
    [J]. AIDS REVIEWS, 2014, 16 (01) : 35 - 42
  • [9] Resistance profile analysis of treatment-experienced HIV-1-infected patients switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) plus darunavir (DRV)
    Margot, Nicolas
    Ram, Renee
    Das, Moupali
    Fordyce, Marshall
    McCallister, Scott
    Miller, Michael
    Callebaut, Christian
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [10] Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study
    Baldin, G.
    Ciccullo, A.
    Capetti, A.
    Rusconi, S.
    Sterrantino, G.
    Cossu, M. V.
    Giacomelli, A.
    Lagi, F.
    Latini, A.
    Bagella, P.
    De Luca, A.
    Di Giambenedetto, S.
    Madeddu, G.
    [J]. HIV MEDICINE, 2019, 20 (02) : 164 - 168
12345